Spravato Insurance Coverage Considerations
Esketamine, administered as the FDA-approved nasal spray Spravato, is indicated for specific adult depression diagnoses, such as treatment-resistant depression. Because it holds FDA approval for psychiatric use, many health insurance plans offer coverage. However, policies vary significantly, and securing coverage typically requires navigating prior authorization requirements. Patients usually must demonstrate that they have tried and failed other traditional antidepressant medications. Deductibles, copayments, and facility fees for the required in-office monitoring period will still apply. Prospective patients should request a detailed written estimate from their clinic to fully understand their out-of-pocket financial responsibilities.
Self-Pay and Compounded Ketamine Costs
Other forms of ketamine, such as IV infusions, intramuscular injections, or oral tablets, are prescribed off-label for mental health conditions. Insurance rarely covers these compounded treatments, meaning patients generally rely on self-pay arrangements. Patients traveling from Villa Rica to clinics in Marietta or Atlanta should also account for the cost of transportation, time off work, and potentially lodging if frequent treatments are necessary. Furthermore, the FDA has issued guidance regarding compounded formulations; patients are encouraged to read the FDA warning on compounded ketamine risks to better understand the safety profile and regulatory status of these off-label therapies.